tldrdaily.news logo
Tag

Ww International

All articles tagged with #ww international

business1 year ago

"Oprah Winfrey's Departure from Weight Watchers Board Sparks Stock Drop and Diet Industry Concerns"

Oprah Winfrey's decision to leave the board of WW International caused the company's stock to plummet by 25%, signaling potential challenges for the weight loss giant. The "Oprah Effect" had previously boosted WW's value, but the company now faces uncertainty in a changing diet culture and the rise of weight-loss medications. As WW seeks a new identity, its pivot to offering weight-loss drugs may shape its future in the evolving wellness industry.

via Business Insider|
#business#oprah-winfrey#stock-market
health-and-wellness2 years ago

WeightWatchers Adapts Program for Weight-Loss Drug Users Following Oprah's Revelation

WeightWatchers, now known as WW International, has launched the WeightWatchers GLP-1 Program, offering behavioral support for individuals using weight-loss drugs such as Ozempic and Wegovy. The program aims to help consumers manage the unique behavioral needs associated with taking GLP-1 medications, providing nutritional guidance, activity targets, and tracking tools. The announcement comes after Oprah Winfrey, a board member of WW International, revealed her use of weight-loss drugs. WW International has been focusing on becoming a more digital and tech-focused weight-management company, acquiring Sequence, a telehealth platform that specializes in chronic weight management and can prescribe weight-loss drugs. The launch of the GLP-1 program reflects the growing popularity and impact of weight-loss drugs, with WW International's stock rising nearly 10% following the announcement.

via Yahoo Finance|
#glp-1-program#health-and-wellness#oprah-winfrey
finance2 years ago

WeightWatchers' Stock Skyrockets on Acquisition Deal and Obesity-Drug Related Optimism

WW International's stock surged 59% after Goldman Sachs analyst Jason English upgraded his rating on the stock to buy from neutral following the company's acquisition of telehealth provider Sequence. English also raised his price target on WW to $13 from $3.80, implying that shares could surge 216% from their close on Monday. The acquisition will help WW access the growing market for new obesity drugs, which should boost its earnings per share and lead the stock higher.

via Yahoo Finance|
#acquisition#finance#obesity-drugs
business2 years ago

Stocks on the Move: Moderna, CarMax, Coinbase, and More

Shares of WW International surged 48% after Goldman Sachs upgraded the diet company to a buy from neutral rating, while CarMax's shares jumped 10% after it announced a beat on its earnings for the fourth quarter. Biotech stock Moderna lost about 4% after the company said that its flu vaccine trial fell short of the criteria for early success in a late-stage trial. Tesla gained 1% in midday trading Tuesday, implementing a slew of new price cuts on its website on Friday. Meanwhile, shares of Akamai Technologies added 2.6% the day after Piper Sandler analyst James Fish upgraded Akamai to overweight from neutral.

via CNBC|
#akamai-technologies#business#carmax
business2 years ago

"Top Stocks to Watch: Moderna, Micron, Tesla, and More"

CarMax beats earnings expectations, causing shares to soar; Newmont raises price proposal to acquire Newcrest Mining, causing stock to drop; JPMorgan initiates coverage of Upstart and LendingClub, with underweight and overweight ratings respectively; Goldman Sachs upgrades Whirlpool to buy and predicts a 20% rally; Moderna delays flu vaccine due to lack of enrolled cases in late-stage trial; Baird initiates coverage of Bumble with outperform rating; Wolfe Research initiates coverage of Array Technologies with outperform rating; Goldman Sachs predicts WW International could triple in value due to new obesity drug on-ramp solution.

via CNBC|
#business#carmax#lendingclub
finance2 years ago

The Ozempic Craze: Weight Loss and Black Market Demand.

Novo Nordisk, Eli Lilly, and WW International are three companies that could benefit from the popularity of Ozempic, a drug that has been effective in helping people lose weight. Novo Nordisk, the maker of Ozempic, is likely to see the biggest benefit, with its higher-dose treatment, Wegovy, also showing promise. Eli Lilly has its own weight-loss treatment, Mounjaro, which could potentially be the best-selling drug ever. WW International recently acquired Sequence, a telehealth platform that offers prescriptions for Ozempic and Wegovy, which could lead to growth for the struggling weight-loss brand.

via The Motley Fool|
#eli-lilly#finance#novo-nordisk